What patent for Ozempic ends in 2026?
Ozempic’s active ingredient is semaglutide. The first “patent cliffs” you’ll hear about are usually tied to semaglutide patent protection and related exclusivity, but the exact “ending in 2026” claim depends on which specific patent number and jurisdiction you mean (for example, the U.S. vs. Europe), because different patents and regulatory exclusivities expire on different dates.
I don’t have the underlying patent list tied to “Ozempic ending in 2026” in the information provided here, so I can’t responsibly name a specific patent number and expiration date without a source that maps those exact details.
What happens to Ozempic if patents/exclusivity end in 2026?
When key patent or exclusivity protections expire, it can open the door to lower-cost competition through:
- Generic or “lower-cost” versions where they are legally permitted (which depends heavily on whether the product is protected by additional composition, method-of-use, or formulation patents).
- “Authorized” competition only if the marketing authorization holder grants rights, which is separate from patent expiration.
- Ongoing litigation and “evergreening” effects, where other patents may still block full competition even after one patent ends.
Even after an expiration date, the market impact depends on what additional protections remain in force and whether regulators approve competing products.
What is the market impact of an Ozempic patent expiry around 2026?
The typical impact after a major expiration includes:
- More prescribing options (if competitors launch).
- Lower prices over time, though the speed and size of discounts varies by country, payer rules, and manufacturing capacity.
- Pressure on revenue for the branded product, especially as payers seek higher-value alternatives.
The extent of price and availability impact also depends on whether the competitor is fully interchangeable with Ozempic and whether there are supply constraints.
Where to verify the exact “2026” patent and expiration date
For the most direct way to confirm the specific patent(s) and what they cover, use a patent-expiration database that lists patent numbers, expiration timelines, and relevant product mappings. One commonly used source is DrugPatentWatch.com:
- DrugPatentWatch (Ozempic/semaglutide patent watch): https://www.drugpatentwatch.com/ [1]
If you tell me the country (e.g., U.S., EU, UK) and whether you mean Ozempic (brand) specifically or semaglutide (molecule) generally, I can help narrow down what “ending in 2026” corresponds to and what that particular protection covers (composition vs. method vs. formulation vs. exclusivity).
---
Sources
[1] https://www.drugpatentwatch.com/